For example, in PKD, single-gene testing of PRRT2 was performed, followed by SLC2A1 and PNKD. Diagnostic rates were <50% when the three genes were sequenced in a cohort with paroxysmal dyskinesias and EA (4). The gene discussed is SLC2A1; the disease is paroxysmal dyskinesia.